Synaffix Patents – Insights & Stats (Updated 2024)

Synaffix has a total of 293 patents globally, out of which 130 have been granted. Of these 293 patents, more than 77% patents are active. United States of America is where Synaffix has filed the maximum number of patents, followed by Europe (EPO) and China. Parallelly, Europe (EPO) seems to be the main focused R&D centre and also Netherlands is the origin country of Synaffix.

Synaffix was founded in the year 2010. The company is a biotech company that focuses on developing advanced techniques for linking molecules together. They specialize in creating innovative methods for mild and efficient protein conjugation, which are used in applications like drug development.

Do read about some of the most popular patents of Synaffix which have been covered by us in this article and also you can find Synaffix patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Synaffix patent portfolio.

How many patents does Synaffix have?

Synaffix has a total of 293 patents globally. These patents belong to 41 unique patent families. Out of 293 patents, 227 patents are active.

How Many Patents did Synaffix File Every Year?

Synaffix Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantSynaffix Applications FiledSynaffix Patents Granted
20241112
20232924
20222017
20213314
2020178
201958
20181323
20172611
2016239
2015362
2014292
201334

How many Synaffix patents are Alive/Dead?

Synaffix Patent Portfolio

How Many Patents did Synaffix File in Different Countries?

Synaffix Worldwide Patent Filing

Countries in which Synaffix Filed Patents

CountryPatents
United States of America47
Europe (EPO)47
China25
Japan25
India21
Germany15
Austria11
Spain6
Poland4
Denmark4
Singapore3
Croatia3
Netherlands3
Portugal3
Hungary3
South Africa3
Australia3
Israel3
Norway3
Slovakia2
Malta2
Serbia2
Slovenia2
Cyprus2
Lithuania2
Mexico2
Albania2
Estonia1
Finland1
Italy1
Korea (South)1

 Where are Research Centres of Synaffix Patents Located?

R&D Centers of Synaffix

10 Best Synaffix Patents

WO2014065661A1 is the most popular patent in the Synaffix portfolio. It has received 326 citations so far from companies like Regeneron Pharmaceuticals, Innate Pharma and Shanghai Miracogen Inc.

Below is the list of 10 most cited patents of Synaffix:

Publication NumberCitation Count
WO2014065661A1326
WO2011136645A1173
WO2016053107A1103
WO2016170186A195
US9222940B275
WO2020094670A167
US20160107999A162
US10266502B256
US8859629B256
US9636421B248

What are Synaffix key innovation segments?

What Technologies are Covered by Synaffix?

The chart below distributes patents filed by Synaffix in different countries on the basis of the technology protected in patents. It also represents the markets where Synaffix thinks it’s important to protect particular technology inventions.

R&D Focus: How has Synaffix search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Synaffix?

Related Articles

Exasun Patents – Insights & Stats (Updated 2024)

Exasun has a total of 15 patents globally, out of which 2 have been granted. Of these 15 patents, more than 80% patents are active. United States of America is where Exasun has filed the maximum number of patents, followed by Europe (EPO) and Netherlands. Parallelly, Netherlands seems to be

Read More »

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.